Cargando…

Pulmonary Function and Respiratory Diseases in Different Genotypes of Alpha-1 Antitrypsin Deficiency

OBJECTIVE: Respiratory disease is the major cause of morbidity and mortality in patients with alpha-1 antitrypsin deficiency, mainly in homozygous PI*ZZ individuals. However, this association is uncertain in subjects with other deficiency genotypes. The objective of this study was to assess, in the...

Descripción completa

Detalles Bibliográficos
Autores principales:	María Hernández Pérez, José, José Suárez Sánchez, Juan, Viviana López Charry, Claudia, Ramallo Fariña, Yolanda, Antonio Pérez Pérez, José
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Turkish Thoracic Society 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9682966/ https://www.ncbi.nlm.nih.gov/pubmed/35957569 http://dx.doi.org/10.5152/TurkThoracJ.2022.22001

Ejemplares similares

Is the determination of C‐reactive protein really necessary in the diagnosis of Alpha‐1 antitrypsin deficiency?
por: Hernández‐Pérez, José María, et al.
Publicado: (2022)

Is there any kind of relationship between alpha-1 antitrypsin levels and lung function parameters?
por: Hernández-Pérez, José María, et al.
Publicado: (2023)

Alpha-1 antitrypsin as a risk marker in SARS-CoV-2 infection
por: Hernández Pérez, José María, et al.
Publicado: (2021)

Serum Levels of Glutamate-Pyruvate Transaminase, Glutamate-Oxaloacetate Transaminase and Gamma-Glutamyl Transferase in 1494 Patients with Various Genotypes for the Alpha-1 Antitrypsin Gene
por: Hernández Pérez, José María, et al.
Publicado: (2020)

COVID-19’s impact on care practice for alpha-1-antitrypsin deficiency patients
por: Calle Rubio, Myriam, et al.
Publicado: (2023)

Heterozygous Alpha-1 Antitrypsin Deficiency Causing Pulmonary Emboli and Pulmonary Bullae
por: Tannous, Toufic, et al.
Publicado: (2021)

Feasibility of a genotyping system for the diagnosis of alpha1 antitrypsin deficiency: a multinational cross-sectional analysis
por: Lopez-Campos, José Luis, et al.
Publicado: (2022)

Evaluation of the Small Airways in Patients with Chronic Obstructive Pulmonary Disease and Alpha-1 Antitrypsin Deficiency
por: Ferrari da Cruz, Thaís, et al.
Publicado: (2020)

Respuesta al artículo prevalencia y características de la enfermedad pulmonar obstructiva crónica en no fumadores
por: Hernández Pérez, José María, et al.
Publicado: (2019)

Detección de casos de déficit de alfa-1 antitripsina, ¿restringimos o ampliamos?
por: Hernández Pérez, José María, et al.
Publicado: (2023)

¿Puede ser la deficiencia de alfa-1 antitripsina un factor protector contra la hipertensión arterial y la cardiopatía isquémica?
por: Hernández Pérez, José María, et al.
Publicado: (2022)

The undiagnosed disease burden associated with alpha-1 antitrypsin deficiency genotypes
por: Nakanishi, Tomoko, et al.
Publicado: (2020)

Acquired alpha 1-antitrypsin deficiency in tropical pulmonary eosinophilia
por: Ray, Debidas, et al.
Publicado: (2011)

Clinical and functional characteristics of individuals with alpha-1 antitrypsin deficiency: EARCO international registry
por: Miravitlles, Marc, et al.
Publicado: (2022)

Genotypic Frequencies of Mutations Associated with Alpha-1 Antitrypsin Deficiency in Unrelated Bone Marrow Donors from the Murcia Region Donor Registry in the Southeast of Spain
por: Cuenca, Irene, et al.
Publicado: (2023)

Mineralization of alpha-1-antitrypsin inclusion bodies in Mmalton alpha-1-antitrypsin deficiency
por: Callea, Francesco, et al.
Publicado: (2018)

Genotyping diagnosis of alpha-1 antitrypsin deficiency in Saudi adults with liver cirrhosis
por: Al-Jameil, Noura, et al.
Publicado: (2017)

Molecular characterization of PI(*)S(hangzhou), a SERPINA1 allele from continental China encoding a defective alpha-1-antitrypsin
por: Hernández-Pérez, José M., et al.
Publicado: (2022)

Alpha-1 antitrypsin deficiency: outstanding questions and future directions
por: Torres-Durán, María, et al.
Publicado: (2018)

Correction: Clinical and functional characteristics of individuals with alpha-1 antitrypsin deficiency: EARCO international registry
por: Miravitlles, Marc, et al.
Publicado: (2023)

Alpha-1 antitrypsin deficiency and risk of lung cancer: A systematic review
por: Tubío-Pérez, Ramón A., et al.
Publicado: (2020)

Alpha 1-antitrypsin deficiency in patients with chronic obstructive pulmonary disease patients: is systematic screening necessary?
por: da Costa, Cláudia Henrique, et al.
Publicado: (2019)

Nebulizers effectiveness on pulmonary delivery of alpha-1 antitrypsin
por: Bianchera, Annalisa, et al.
Publicado: (2023)

The parallel lives of alpha(1)-antitrypsin deficiency and pulmonary alveolar proteinosis
por: Trapnell, Bruce C, et al.
Publicado: (2013)

Alternative transcripts of the SERPINA1 gene in alpha-1 antitrypsin deficiency
por: Matamala, Nerea, et al.
Publicado: (2015)

Gene therapy for alpha 1-antitrypsin deficiency with an oxidant-resistant human alpha 1-antitrypsin
por: Sosulski, Meredith L., et al.
Publicado: (2020)

Alpha-1 Antitrypsin as a Therapeutic Agent for Conditions not Associated with Alpha-1 Antitrypsin Deficiency
por: Wanner, Adam
Publicado: (2015)

Prevalence of genetic mutations in alpha-1 antitrypsin deficiency (aatd) in patients with chronic obstructive pulmonary disease in Colombia
por: Alí-Munive, Abraham, et al.
Publicado: (2023)

Recommendations for the Implementation of the Self-Administration of Alpha-1 Antitrypsin
por: Torres-Durán, María, et al.
Publicado: (2023)

Implications of a Change of Paradigm in Alpha1 Antitrypsin Deficiency Augmentation Therapy: From Biochemical to Clinical Efficacy
por: López-Campos, José Luis, et al.
Publicado: (2020)

Demographic and clinical characteristics of patients with α(1)-antitrypsin deficiency genotypes PI*ZZ and PI*SZ in the Spanish registry of EARCO
por: Torres-Durán, María, et al.
Publicado: (2022)

Safety and efficacy of alpha-1-antitrypsin augmentation therapy in the treatment of patients with alpha-1-antitrypsin deficiency
por: Petrache, Irina, et al.
Publicado: (2009)

alpha1-Antitrypsin deficiency and hepatocellular cancer.
por: Kew, M. C., et al.
Publicado: (1978)

The prevalence of alpha-1 antitrypsin deficiency in Ireland
por: Carroll, Tomás P, et al.
Publicado: (2011)

Alpha-1 Antitrypsin Deficiency: The Learning Goes On
por: Stockley, Robert. A.
Publicado: (2020)

Monocytes and Macrophages in Alpha-1 Antitrypsin Deficiency
por: Belchamber, Kylie B R, et al.
Publicado: (2020)

Alpha-1 Antitrypsin Deficiency: Home Therapy
por: Annunziata, Anna, et al.
Publicado: (2021)

Update on and future perspectives for the diagnosis of alpha-1 antitrypsin deficiency in Brazil
por: Jardim, José R, et al.
Publicado: (2021)

Alpha-1 Antitrypsin Deficiency in Iranian Patients with Chronic Obstructive Pulmonary Disease
por: Geramizadeh, Bita, et al.
Publicado: (2013)

Alpha-1 antitrypsin genotypes in breast cancer patients
por: El-Akawi, Z, et al.
Publicado: (2005)

Cannot write session to /tmp/vufind_sessions/sess_kngfkjrkguepm2gtl4mcurh69p